MENU
+Compare
LQDA
Stock ticker: NASDAQ
AS OF
Mar 28 closing price
Price
$15.09
Change
-$0.15 (-0.98%)
Capitalization
1.3B

LQDA Liquidia Corp Forecast, Technical & Fundamental Analysis

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LQDA with price predictions
Mar 28, 2025

LQDA's RSI Oscillator ascending out of oversold territory

The RSI Indicator for LQDA moved out of oversold territory on March 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 20, 2025. You may want to consider a long position or call options on LQDA as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LQDA just turned positive on March 21, 2025. Looking at past instances where LQDA's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

LQDA moved above its 50-day moving average on March 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LQDA crossed bullishly above the 50-day moving average on March 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LQDA advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

LQDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where LQDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LQDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LQDA entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LQDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.667) is normal, around the industry mean (14.018). P/E Ratio (0.000) is within average values for comparable stocks, (64.861). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.895). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (84.746) is also within normal values, averaging (257.773).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LQDA is expected to report earnings to fall 10.13% to -40 cents per share on May 08

Liquidia Corp LQDA Stock Earnings Reports
Q1'25
Est.
$-0.40
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.07
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.23
The last earnings report on March 19 showed earnings per share of -44 cents, missing the estimate of -38 cents. With 588.56K shares outstanding, the current market capitalization sits at 1.30B.
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLBBX35.73N/A
N/A
Plumb Balanced Investor
PIEQX17.25N/A
N/A
T. Rowe Price International Eq Index
MGRVX43.97N/A
N/A
MFS International Growth R4
CHCLX10.65N/A
N/A
AB Discovery Growth A
MOINX22.29-0.49
-2.15%
NYLI WMC Small Companies Investor Class

LQDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with ALNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
-0.98%
ALNY - LQDA
37%
Loosely correlated
-0.94%
AXON - LQDA
32%
Poorly correlated
-2.85%
AVXL - LQDA
30%
Poorly correlated
-8.60%
XERS - LQDA
29%
Poorly correlated
-0.89%
KURA - LQDA
29%
Poorly correlated
-1.26%
More